Wayne Duran
Auburn, WANPI 1912099383
Payments from drug & device makers
$1,433in general payments, 2019–2025
Across 75 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$317
- AbbVie$221
- AstraZeneca$145
- Teva Pharmaceuticals USA, Inc.$110
- Pfizer$103
- Bausch Health US, LLC$78
- plus $459 from 15 others
What the payments were for
- Food & beverage$1,433100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 15 | $317 |
| AbbVie(2 entities) | 11 | $221 |
| AstraZeneca | 7 | $145 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Pfizer | 6 | $103 |
| Bausch Health US, LLC | 5 | $78 |
| Lilly USA, LLC | 4 | $66 |
| Genentech USA, Inc. | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $38 |
| Merck | 2 | $34 |
| Boehringer Ingelheim | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $26 |
| Antares Pharma, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| MDD US Operations, LLC | 1 | $15 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 17 | $470 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $309 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $301 |
| Atorvastatin Calcium | 17 | $155 |
| Estradiol | 13 | $131 |
| Levothyroxine Sodium | 18 | $122 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.